Abstract:

The review of the article identifies Tuberculosis (TB) as an infectious disease which is known worldwide with reference to India being the second largest populated country in the world. Secondly it identifies Acid Fast Bacilli using Zielh-Neelson (Z-N) staining in a clinical laboratory for the identification of TB using the best possible method to obtain secretions from the lower airways of patients as compared to bacterial identification which is normally used.

Various diagnostic methods and materials used to evaluate the article authority and accuracy will be outlined which includes sample study, period of examination, ethical practices prior starting the study, study protocol, study design, inclusion and exclusion criteria carried out systematically under sterile conditions.

Analysis of AFB smear will be explained and presented using tables which are instrumental in the identification of other diagnostic methods like sputum smear microscopy and X-ray method. Conclusion of the study will be based on the safest method for identification of the organism, which is cost effective and has the potential to offer treatment to the suspected patients. On the other hand, the article has obtained its objectivity and coverage by using various ethical committees and by declaring no conflict of interest among the authors who have contributed equally to the study.

Finally, the evaluation of the article will be carried through the use of well designed and précised questionnaires, a case sheet proforma plus relevant referees attached to the article to aid more understanding.

References:

[1.] Andrew, L., diagnostic surgical pathology of the head and neck, 2009, 2nd edition, 647 – 727.

[2.] Alexander, JrC., (2010). differential diagnosis in surgical pathology of the lung and pleura, 2^nd edition, 217 – 280.

[3.] Barnard, R., & AM, J., (2008) Rapid Molecular Screening for multidrug- resistant tuberculosis in a high volume public health laboratory, 177:787 – 792, South Africa.

[4.] Brooks, GF et al (1995): Jawetz, Melnick, & Adelberg’s Medical Microbiology, 21ST International Edition, Prentice Hall International Limited, London, UK, 134 – 144.

[5.] Caviedes, L., & LEE, TS., (2000). Rapid efficient detection and drug susceptibility testing of Mycobacterium Tuberculosis in sputum by microscopic observation of broth cultures; 38; 1203 – 1208, tuberculosis working groups in Peru.

[6.] Centres for Disease Control and Prevention, MMWR Recomm, 2002, sexually transmitted diseases treatment guidelines, 51(RR – 6): 1 – 78.

[7.] Gavino, M., &Wang, E., (2007)., a comparison of a new rapid real – time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization.

[8.] Goldman’s Cecil medicine,(2012), non tuberculous mycobacteria, volume 2, pages 1948 – 1950, 24th edition, Steven M. Holland.

[9.] Margret, S., et al, 2009, nonsquamous pathological diseases of the hypophyarnx, larynx and trachea, chapter 5, 2nd edition and pages 309 – 411.

[10.]   Mitnick, CD., & S.S. (2008)., comprehensive treatment of extensively drug – resistant tuberculosis. N. Engl. J. MED, 359; 563 – 54.

[11.]   Nakajima et al 2010, identification of mycobacterium tuberculosis clinical isolates in Bangladesh by species distinguishable multiplex PCR, 10:118, http:/ www.Biomedcentral.com/1471 – 2334/10/118.

[12.]   Rutala, W.A., & D.J. (2002)., draft guideline for disinfection and sterilization in healthcare facilities, centres for disease control and prevention, Atlanta.

[13.]   Steven, L., (2014). microbiology of waterborne diseases, second edition, chapter nine pages 177 – 207. Mycobacterium.

[14.]   Temple, I.. Ayakaka, S., & Ogwang, (2008). rate and amplification of drug resistance among previously treated patients with tuberculosis in Kampala, Uganda; 47:1/26 – 1134.

[15.]   Basil, MVH., (2004). Rapid detection of rifampin resistance in mycobacterium tuberculosis isolates from India and Mexico by a molecular bacon assay. 42:5512 – 5516.

[16.]   World Health Organization, WHO/IUATLD global project, 2008 Anti – tuberculosis drug resistance in the world. Publication number WHO/HTM/TB 2008:394, WHO, Geneva and Switzerland.